Volume 18, No. 2, 2020 Case Study - Collective Defined Contribution Plans Seoyoung Kim View PDF… Read More
Case Studies
Fair and Responsible Drug Pricing: A Case Study of Radius Health and Abaloparatide
Volume 18, No. 1, 2020 Qingyang Xu and Andrew W. Lo View PDF… Read More
Case Study – Do You Know the Provenance of Your Alternative Data
Vol. 17, No. 3, 2019 Seoyoung Kim View PDF… Read More
Case Study – Using Social Media Analytics in the Management of Investment Management
Volume 17, No. 2, 2019 Seoyoung Kim View PDF… Read More
Pricing for Survival in the Biopharma Industry: A Case Study of Acthar Gel and Questcor Pharmaceuticals
Volume 15, Number 4, 2017 Terence C. Burnham, Samuel Huang and Andrew W. Lo Recent cases of aggressive pricing behavior in the biopharmaceutical industry have raised serious concerns among payers and policymakers about industry ethics. However, these cases should not be confused with price increases motivated by challenging business conditions that ultimately lead to greater… Read More
Case Study – Portfolio Manager Selection
Volume 15 , Number 3, 2017 Michael Christensen View PDF… Read More
Case Study – The Rational Investor
Volume 15, Number 2, 2017 Craig French View PDF… Read More
The Revolving Door
Volume 15, No. 1, 2017 Craig W. French View PDF… Read More
Business Models to Cure Rare Disease: A Case Study of Solid Biosciences
Esther S. Kim and Andrew W. Lo Volume 14, Number 4 , Four Quarter 2016 View PDF… Read More
Case Study – Developing Countries
Case Study Volume 14, Number 3 , Third Quarter 2016 View PDF… Read More